Feb 7th 2023 - Mar 21st 2023
Super excited for tomorrow's ER Guidance Call ... See more
They're FDA approved, have the best in class t... See more
Feb 7th 2023 - Mar 21st 2023
$AVXL I am extremely bullish on the data .. the F... See more
Guys from the fda that really know their stuff.
The Motley Fool Stock Advisor has a track record that speaks for itself, with average recommendations that have returned over 542%*. Act now so you can start investing smarter, not harder.
*As of October 2023$79 is an introductory price for new members only. 60% discount based on the current list price of Stock Advisor of $199/year. Membership will renew annually at the then current list price.Feb 7th 2023 - Mar 21st 2023
$CDTX FDA decision will be made tomorrow $SAVA, $M... See more
$SAVA FDA approved Biogen's AD drug is bullish for SAVA.
Super excited for tomorrow's ER Guidance Call for our first ever FDA approved commercialized product, Briumvi!
They're FDA approved, have the best in class treatment, and is more affordable than the others.
$JAZZ $TGTX FDA APPROVED ON 12/28/22 . BUY/HOLD/ACCUMULATE
$KALA up 46%, rallies 3rd day in a row following FDA acceptance of IND application of KPI-012 & $TGTX is up 13% continued momentum following MS drug approvals.
Our best in class drug is FDA APPROVED.
$TGTX $KALA $HOTH $NUWE TGTX on fire 🔥 and solid from fundamentals perspective after yesterday FDA approval of Multiple Sclerosis Billion dollar drug revenue potential.
Great FDA approval news in a growing MS market with a need.
$TGTX , absolutely amazing….Scumbag’s Bank of America analyst rated TG today as underperform $6….total joke….I guess the analyst is waiting for FDA approval…LOL ….stick to loans and mortgages….very bullish TG community Longs….
$TGTX FDA approval for Billion dollar MS drug — great things in store 2023 $DRMA just officially dropped offering, makes me feel company has something good up it’s sleeve.
.. FDA APPROVED ON 12/28/22 BEST IN CLASS .
$AVXL I am extremely bullish on the data .. the FDA can ask any sorts of questions
Guys from the fda that really know their stuff.
He said Anavex could do that also and all of that makes Anavex pleased how easy the FDA wants to make Accelerated approval here.
The FDA and global agencies find great comfort in NDAs accompanied by a peer review.
look into Adamis Pharma, no more speculation, now it's real, two FDA approved meds, two major products, top of the line in comparison of their rivals, for cheaper price, AND WITH NO MUCH COMPETITION!
With all the scrutiny with on the FDA they will definitely be forced to approve Anavex which is the safest, cheapest on Healthcare and the patients, and most convenient drug.
$AVXL good thing they have 50 years of fda expertise on their staff, HandF😘
This puts alot of scrutiny on the FDA which is good for Anavex.
Suddenly the results could look golden and backed by the FDA allowable genetic coding regulations!!
$CDTX FDA decision will be made tomorrow $SAVA, $MDGL & $RETA boys I can easily see this up 200%-300% in my opinion on an approval.
$SAVA FDA approved Biogen's AD drug is bullish for SAVA.
no more speculation, now it's real, two FDA approved meds, two major products, top of the line in comparison of their rivals, for cheaper price, AND WITH NO MUCH COMPETITION!
$SAVA When FDA approved Aduhelm (aducanumab), which was a failure, on June 7 2021, SAVA was up 33% within a day following that news! !
My prediction: Phase 2 Unbelievable results FDA fast track Phase 3 - go ahead Patients receive sava Market cap 40 B by 2024 Rising to 200 Billion by 2026 Game changer - the only drug in the world to help patients
This formula has already proved to be effective, and if FDA approved can potentially be sold for billions.
FDA, do the right thing this time!
$SAVA the drug is 100% safe the fda has nothing to lose if they approve it for compassionate use.
Should be place on fast track by the FDA!
